Novartis – Medical Alley Association

Novartis

In the Know: Healthcare News for September 28, 2020

Bright Health Inc. Announces $500 Million Series E Funding Including Significant Investments by Tiger Global Management, T. Rowe Price Associates, Blackstone, NEA and Bessemer Venture Partners Bind Launches Into the Fully-insured Market Spineology Gets FDA De Novo Grant of Minimally Invasive OptiMesh Expandable Interbody Fusion System Medtronic gains breakthrough nod for VAD driveline Fast Company […]

Novartis commits to donate up to 130 million doses of hydroxychloroquine to support the global COVID-19 pandemic response

Hydroxychloroquine and a related drug, chloroquine, are currently under evaluation in clinical trials for the treatment of COVID-19.  Novartis Sandoz division will pursue appropriate regulatory authorizations and, upon approval, will work with stakeholders to determine how best to get this medicine to the patients who need it  Commitment builds on recently announced USD 20 million […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER